English | Español

Regulatory
+ Regulatory
Jamie Barrand | Sep 23, 2015

Group hails CMS for expanding out-of-pocket cost limits
+ Regulatory
Jamie Barrand | Sep 18, 2015

Proposed policies could hinder U.S. medical progress

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes